MEDIROM Healthcare Technologies Inc. Announces Pricing of Upsized $12.0 Million Initial Public Offering and Listing on NASDAQ New York/

MEDIROM Healthcare Technologies Inc.

Announces Pricing of Upsized $12.0 Million Initial Public

Offering and Listing on NASDAQ

New York/December 28, 2020 -

MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM) ("MEDIROM"), the holistic healthcare company from Japan, announced

the pricing of its initial public offering of 800,000 American Depositary Shares (ADSs) at a price of US$15.00 per ADS. Each ADS

represents one common share of MEDIROM. The ADSs are expected to begin trading on the Nasdaq Capital Market on December 29,

2020, under the symbol "MRM." Gross proceeds before deducting underwriting discounts and commissions and other offering

expenses are expected to be US$12.0 million. The closing of the offering is expected to occur on December 31, 2020, subject

to the satisfaction of customary closing conditions.

In addition the Company has granted the

underwriters a 45-day option to purchase up to an additional 120,000 ADSs at the public offering price, less underwriting discounts

and commissions to cover over-allotments, if any.

Group LLC is acting as the sole book-running manager in connection with the offering.

The Company intends to use the net proceeds

from the offering for working capital and general corporate purposes, which may include investments, acquisition or strategic collaborations

to expand its customer base as well as develop and market new services.

offering is being conducted pursuant to the Company's registration statement on Form F-1 (File Nos. 333-250762 and 333-251777)

previously filed with and subsequently declared effective by the Securities and Exchange Commission ("SEC"). A prospectus

relating to the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov. Electronic

copies of the prospectus relating to this offering, when available, may be obtained from Maxim Group LLC, 405 Lexington Avenue,

2nd Floor, New York, NY 10174, at (212) 895-3745.

press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, any

security in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration

or qualification under the securities laws of any such state or other jurisdiction.

MEDIROM Healthcare Technologies Inc.

operates 289 (as of June 30, 2020) relaxation salons across Japan centered around Re.Ra.Ku , which aims to provide healthcare

services. In 2015, MEDIROM entered the health tech business, and conducted specific health guidance and constitution improvement

programs, On-demand training app "Lav ". MEDIROM also entered the device business in 2020, and is developing

a smart tracker "MOTHER Tracker ". Currently, MEDIROM is continuing development work with the goal of commercializing

the product. In the future, MEDIROM plans to expand the scope of our business to include data analysis based on the lifestyle data

we have accumulated since our founding.

Overview of MEDIROM Healthcare Technologies

Company Name: MEDIROM Healthcare Technologies

Headquarters: Tradepia Odaiba, 2-3-1 Daiba,

CEO/Founder: Kouji Eguchi

Establishment: July 2000

Paid-in Capital: JPY 1,303,008,037 (as

of December 31, 2019)

Business Area: Relaxation Salon Management,

Related Franchise Business, Digital Health Promotion Business and Devices Business

Investor Relations Team

Public Relations Team